Loading
BA
Biostar Angel Stem Cell Corp Stock: price and insider trades · United States
Biostar Angel Stem Cell Corp: what insiders have been doing
Biostar Angel Stem Cell Corp is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Biostar Angel Stem Cell Corp. The previous disclosure was published on 25 May 2018.
Looking back to 2018, when coverage begins, insiders filed no purchases and 2 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€16B
2 ops. · all time
Financial data
as of FY 2018FY ended September 2018 · cache
Last declaration on 25 May 2018
Declarations3 total
30,000 shares0Common StockSEC:0001493152-18-007879:0
9,750,000 shares@ US$975.00common stockSEC:0001021432-18-000005:0
9,750,000 shares@ US$975.00common stockSEC:0001021432-18-000006:0
3 of 3 declarations
About Biostar Angel Stem Cell Corp
Biostar Angel Stem Cell Corp is a company focused on the research and development of stem cell-based therapies. It is listed on the XNAS market.
